Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

77 ELEKTRONIKA

Develops, manufactures, and markets fully automated and semi-automated urine analyzers, blood glucose meters, rapid t... read more Featured Products: More products

Download Mobile App




Automated Urine Microscope Verified for Regional Laboratories

By LabMedica International staff writers
Posted on 03 Feb 2021
Automated Urine Microscopy examines a sample of urine under a microscope. More...
It can check cells from the urinary tract, blood cells, crystals, bacteria, parasites, and cells from tumors. This test is often used to confirm the findings of other tests or add information to a diagnosis.

Automation of urine particle counting has become a clinical standard in medium-sized and large laboratories by means of flow cytometry or several types of image analyzers. Reliable implementation of those instruments requires utilization of reference procedures in their verification.

Clinical Chemists and Microbiologists from Helsinki University Hospital (Helsinki, Finland) carried out the primary verification with 463 urine specimens, and against urine culture on chromogenic agar plates with 396 parallel specimens. Nine secondary instruments were compared pairwise with the primary instrument. Both mid-stream collections (generally 90% of all specimens) and catheterized specimens were taken into the study, based on particle findings.

Specimens were chosen from routine analysis by UF-1000i instrument (Sysmex, Kobe, Japan) for verification of the primary (“Gold”) UriSed 3 PRO instrument (77 Elektronika, Budapest, Hungary) against reference visual microscopy during a 6-week period in September - October 2018. Comparisons to urine culture results were available for 396 parallel samples which were cultured by using automated inoculation with 1 µL loop (WASP automated microbiology instrument, COPAN Wasp, Brescia, Italy) on chromogenic agar plates (CHROMagar Orientation medium, CHROMagar, Paris, France) following incubation at 35 °C for 18 hours.

The scientists reported that relative imprecisions compared to Poisson distribution, R(CV), were estimated to be 1.0 for white blood cell (WBC) and 1.5 for red blood cell (RBC) counts, respectively. Spearman’s correlations against visual microscopy were rS = 0.94 for WBC, rS = 0.87 for RBC, and rS = 0.82 for squamous epithelial cell (SEC) counts. Agreement with visual microscopy (Cohen’s weighted kappa) was 0.94 for WBC, 0.89 for RBC, 0.88 for SEC, 0.59 for combined casts, and 0.49 for non-squamous epithelial cells (NEC). Bacteria were detected with a sensitivity of 90% and specificity of 39 against culture at 107 colony forming bacteria/L (CFB/L = 104 CFU/mL). Created flagging limits allowed automated reporting for 70-75 % of patient results.

The authors were able to install 10 UriSed 3 PRO instruments in a regional laboratory environment at HUSLAB, providing about 160,000 automated particle counts annually at 24/7 basis, thus satisfying both routine testing and emergency analysis of clinical samples. Analytical performance fulfilled the analytical performance specifications and expectations obtained from preliminary testing. The study was published on January 26, 2021 in the journal Clinica Chimica Acta.

Related Links:
Helsinki University Hospital
Sysmex
77 Elektronika
COPAN Wasp
CHROMagar


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.